For example, HER2/HER2 status is not correlated with prognosis in a cohort consisting of stage I-IV resectable GC patients; however, a negative correlation is apparent in stage III/IV patients (Kataoka et al. 2013). The gene discussed is ERBB2; the disease is gastric cancer.